載入...
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
The successful treatment of certain autoimmune conditions with the humanized anti–IL-6 receptor (IL-6R) antibody tocilizumab has emphasized the clinical importance of cytokines that signal through the β-receptor subunit glycoprotein 130 (gp130). In this Review, we explore how gp130 signaling control...
Na minha lista:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Clinical Investigation
2011
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3163962/ https://ncbi.nlm.nih.gov/pubmed/21881215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI57158 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|